About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,766 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,766 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2601-2620 of 4,766 trials

UnknownEffects of Chewing Gum Against Postoperative IleusThe purpose of this study is to determine whether the use of chewing gum effects postoperative ileus after pancreaticoduodenectomyNCT04768660 CompletedPancreatic Anastomosis After DuodenopancreatectomyA national, multicenter, randomized, prospective, parallel group clinical study to evaluate two therapeutic strategies (invaginating pancreatogastric anastomosis versus Blumgart…NCT04462354·Valencia UnknownPancreatic Cancer & Surgical ResectionPrimary Objective(s) To collect clinical data related to the treatment outcomes of Pancreatic IRE in order to develop an evidence base such that physicians can provide the best…NCT05170802·Dallas, Texas CompletedNeoantigen Vaccines in Pancreatic Cancer in the Window Prior to SurgeryThis is a randomized phase 1 clinical trial to evaluate the safety of an optimized neoantigen synthetic long peptide (SLP) vaccines in pancreatic cancer patients following…NCT05111353·St Louis, Missouri

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

CompletedA Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic CancerObjectives * Primary: To evaluate the safety and tolerability of FG-3019 in combination with gemcitabine and erlotinib * Secondary: To evaluate the efficacy and pharmacokinetics…NCT01181245·Stanford, California and 6 others

TerminatedHigh or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well high or standard intensity radiochemotherapy after gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle…NCT01921751·Oakland, California and 45 others

TerminatedEvaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic CancerThis is a dose-seeking study that will test the safety of increasing doses of Rexin-G, given intravenously, in patients with advanced or metastatic pancreatic cancer who have…NCT00121745·Rochester, Minnesota

WithdrawnDynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungThis phase I trial studies the side effects of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in patients with advanced breast or pancreatic cancer with metastases…NCT01741597·Duarte, California

RecruitingIN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic CancerThis study is a multicenter, open-label, single-arm, phase Ib/II clinical study comprising two phases: dose confirmation phase and dose expansion phase.NCT05827796·Shanghai, Shanghai Municipality

WithdrawnModified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid LesionsThe purpose of the study is to compare two particular techniques of tissue (capillary vs wet-suction techniques) sampling during endoscopic ultrasound guided fine needle…NCT02919553

CompletedChina CellSearch StudyThe study is designed to confirm the current indication (below) of the CellSearch® Circulating Tumor Cell Kit in metastatic breast cancer (MBC) patients for use of the kit in…NCT01116869·Beijing

TerminatedDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsRATIONALE: Drugs used in chemotherapy, such as doxorubicin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00730483·Baltimore, Maryland

Active not recruitingTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerThis phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer…NCT04340141·Birmingham, Alabama and 452 others

RecruitingCarcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenA Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of…NCT07087054·Gilbert, Arizona and 72 others

TerminatedIrreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic CancerThe trial investigates the safety and efficacy of irreversible electroporation in combination with checkpoint inhibition in patients with metastatic pancreatic cancer.NCT05435053·Roskilde

TerminatedPreoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic CancerPancreatic cancer continues to have a poor prognosis. Many patients are diagnosed with advanced disease.NCT04136769·Halle and 2 others

RecruitingBMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic AdenocarcinomaThis phase II trial tests the safety, side effects and best dose of BMS-986340 in combination with nivolumab, gemcitabine, and nab-paclitaxel and how well it works in treating…NCT07226856·Scottsdale, Arizona and 2 others

TerminatedBasket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and DostarlimabTreatment will consist of a PARP inhibitor (niraparib) monotherapy priming period (cycle 0; 21 days); an anti-PD-1 antibody (Dostarlimab ; TSR-042) will then be added from C1D1…NCT04779151·Villejuif, Val de Marne

TerminatedEndoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic HeadThe prognosis of patients with unresectable pancreatic cancer is dismal.NCT00753441·Heidelberg

UnknownUsefulness of the Artery First Approach in Pancreatic Cancer SurgeryThis study is aimed to evaluate difference of the 2 year recurrence free survival after pancreaticoduodenectomy for pancreatic cancer between artery-first approach and…NCT04136522·Seoul

PreviousPage 131 of 239Next